HLA-A2.1 Publications

HLA-A2.1 Model Page

Filter publications by application: All HIV Infectious Disease Myeloma Oncology Vaccine Research
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Tan AC, et al.
Mouse over for full list
Tan AC, La Gruta NL, Zeng W, Jackson DC
(2011) Precursor frequency and competition dictate the HLA-A2-restricted CD8+ T cell responses to influenza A infection and vaccination in HLA-A2.1 transgenic mice. J. Immunol. 187(4):1895-902
Infectious Disease, Vaccine Research
Singh RA, et al.
Mouse over for full list
Singh RA, Barry MA
(2003) Generation of multivalent genome-wide T cell responses in HLA-A*0201 transgenic mice by an HIV-1 expression library immunization (ELI) vaccine. Res Initiat Treat Action 8(2):17-9
Infectious Disease, HIV, Vaccine Research
Singh RA, et al.
Mouse over for full list
Singh RA, Wu L, Barry MA
(2002) Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine. J. Immunol. 168(1):379-91
Infectious Disease, HIV, Vaccine Research
Pasquetto V, et al.
Mouse over for full list
Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, Peters B, Southwood S, Cerundolo V, Grey H, Yewdell JW, Sette A
(2005) HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J. Immunol. 175(8):5504-15
Infectious Disease
Nanjundappa RH, et al.
Mouse over for full list
Nanjundappa RH, Wang R, Xie Y, Umeshappa CS, Xiang J
(2012) Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice. Vaccine 30(24):3519-25
Vaccine Research
Kang YJ, et al.
Mouse over for full list
Kang YJ, Zeng W, Song W, Reinhold B, Choi J, Brusic V, Yamashita T, Munshi A, Li C, Minvielle S, Anderson KC, Munshi N, Reinherz EL, Sasada T
(2013) Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma. Br. J. Haematol. 163(3):343-51
Oncology, Myeloma, Vaccine Research
Casnici C, et al.
Mouse over for full list
Casnici C, Volpe G, Crotta K, Lattuada D, Saglio G, Marelli O
(2012) Immunologic evaluation of peptides derived from BCR/ABL-out-of-frame fusion protein in HLA A2.1 transgenic mice. J. Immunother. 35(4):321-8
Oncology, Vaccine Research
Botten J, et al.
Mouse over for full list
Botten J, Alexander J, Pasquetto V, Sidney J, Barrowman P, Ting J, Peters B, Southwood S, Stewart B, Rodriguez-Carreno MP, Mothe B, Whitton JL, Sette A, Buchmeier MJ
(2006) Identification of protective Lassa virus epitopes that are restricted by HLA-A2. J. Virol. 80(17):8351-61
Infectious Disease, Vaccine Research
Yoshida M, et al.
Mouse over for full list
Yoshida M, Ishioka Y, Ozawa T, Okuyama H, Iguchi M, Ota T, Ito T, Nagira M, Morita A, Tanaka H, Naito H, Kidoya H, Takakura N
(2017) Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency. Sci Rep 7(1):11137
Vaccine Research
Testa JS, et al.
Mouse over for full list
Testa JS, Shetty V, Hafner J, Nickens Z, Kamal S, Sinnathamby G, Philip R
(2012) MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. PLoS ONE 7(11):e48484
Vitiello A, et al.
Mouse over for full list
Vitiello A, Marchesini D, Furze J, Sherman LA, Chesnut RW
(1991) Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 173(4):1007-15
Men Y, et al.
Mouse over for full list
Men Y, Miconnet I, Valmori D, Rimoldi D, Cerottini JC, Romero P
(1999) Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J. Immunol. 162(6):3566-73
Vaccine Research
Cong H, et al.
Mouse over for full list
Cong H, Mui EJ, Witola WH, Sidney J, Alexander J, Sette A, Maewal A, McLeod R
(2011) Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201. Vaccine 29(4):754-62
Infectious Disease, Vaccine Research
Botten J, et al.
Mouse over for full list
Botten J, Whitton JL, Barrowman P, Sidney J, Whitmire JK, Alexander J, Ting JP, Bui HH, Sette A, Buchmeier MJ
(2007) HLA-A2-restricted protection against lethal lymphocytic choriomeningitis. J. Virol. 81(5):2307-17